SOCS3 and breast carcinoma: Consistent with the above results, we found that SOCS3 was significantly decreased in primary breast cancer MDSCs and induced MDSCs and was significantly correlated with sustained activation of the JAK/STAT signaling pathway and enhanced T cells immunosuppression in MDSCs.